Cycling, doping & the importance of due process: A review of the Karl Murray caseAni Ghazikhanian No Comments
In a decision1 dated 13 October 2017, a Panel from Sports Tribunal of New Zealand found cyclist Karl Murray liable for committing an anti-doping rule violation. Murray was competing in the Tour of Northland when he tested positive for Clenbuterol2 in a sample provided on 18 March 2017.
This article reviews the Tribunal’s decision, looking specifically at:
Continue reading this article...
Already a member? Sign in
Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts. Find out more here.
- Tags: Anti-Doping | Board of Drug Free Sport New Zealand | Cycling | New Zealand | Prohibited List | WADA Code 2015 | WADA International Standard for Testing and Investigations (ISTI) | World Anti-Doping Agency (WADA)
- U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for Anti-Doping Rule Violation
- Powerful partnership to tackle improper PED prescriptions
- UK Anti-Doping Releases Findings into its Cycling Investigation
About the Author
Ani Ghazikhanian is a third year law student at the University of Notre Dame Law School in the United States with a specific interest in sports law. She is interning with LawInSport and studying in London as part of the Notre Dame London Program for Fall 2017. Previous work experience includes interning with the NFL's Minnesota Vikings' in-house counsel.